NDC Compounded Drug 60652-4272-1 Fentanyl Citrate; Ropivacaine Hydrochloride
Injection Epidural
Compounded Drug Product Information
NDC Crossover Products Matching Fentanyl Citrate; Ropivacaine Hydrochloride
NDC crossover of Fentanyl/ropivacaine with NDC 60652-4272 a human compounded drug with other similar products matching the same substance name (Fentanyl Citrate; Ropivacaine Hydrochloride) and the same administration route (epidural) or dosage form (injection).
NDC | Proprietary Name | Non-Proprietary Name | Package Desc | Dosage Form | Route Name | Company Name |
---|---|---|---|---|---|---|
70092-108-36 | Fent 2 Mcg/ml-ropiv 0.2% Pf 100ml Ns Ivb | Fent 2 Mcg/ml-ropiv 0.2% Pf 100ml Ns Ivb | 100 mL in 1 BAG | Injection | Epidural | Quva Pharma, Inc. |
70092-108-36 | Fent 2 Mcg/ml-ropiv 0.2% Pf 100ml Ns Ivb | Fent 2 Mcg/ml-ropiv 0.2% Pf 100ml Ns Ivb | 100 mL in 1 BAG | Injection | Epidural | Quva Pharma, Inc. |
70092-108-36 | Fent 2 Mcg/ml-ropiv 0.2% Pf 100ml Ns Ivb | Fent 2 Mcg/ml-ropiv 0.2% Pf 100ml Ns Ivb | 100 mL in 1 BAG | Injection | Epidural | Quva Pharma, Inc. |
70092-108-36 | Fent 2 Mcg/ml-ropiv 0.2% Pf 100ml Ns Ivb | Fent 2 Mcg/ml-ropiv 0.2% Pf 100ml Ns Ivb | 100 mL in 1 BAG | Injection | Epidural | Quva Pharma, Inc. |
70092-207-37 | Fent2mcg/ml-ropiv0.1%pf 200ml Ns- 250ivb | Fent2mcg/ml-ropiv0.1%pf 200ml Ns- 250ivb | 200 mL in 1 CARTRIDGE | Injection | Epidural | Quva Pharma, Inc. |
70092-225-37 | Fent 2 Mcg/ml-ropiv 0.2% Pf 250ml Ns Ivb | Fent 2 Mcg/ml-ropiv 0.2% Pf 250ml Ns Ivb | 250 mL in 1 BAG | Injection | Epidural | Quva Pharma, Inc. |
70092-225-37 | Fent 2 Mcg/ml-ropiv 0.2% Pf 250ml Ns Ivb | Fent 2 Mcg/ml-ropiv 0.2% Pf 250ml Ns Ivb | 250 mL in 1 BAG | Injection | Epidural | Quva Pharma, Inc. |
70092-399-75 | Fent2mcg/ml-rop0.1% Pf100mlns Cadd-yfsff | Fent2mcg/ml-rop0.1% Pf100mlns Cadd-yfsff | 200 mL in 1 CARTRIDGE | Injection | Epidural | Quva Pharma, Inc. |
70092-399-75 | Fent2mcg/ml-rop0.1% Pf100mlns Cadd-yfsff | Fent2mcg/ml-rop0.1% Pf100mlns Cadd-yfsff | 200 mL in 1 CARTRIDGE | Injection | Epidural | Quva Pharma, Inc. |
70092-441-76 | Fent2mcg/ml-rop0.1% Pf200mlns Cadd-yfsff | Fent2mcg/ml-rop0.1% Pf200mlns Cadd-yfsff | 200 mL in 1 CARTRIDGE | Injection | Epidural | Quva Pharma, Inc. |
70092-441-76 | Fent2mcg/ml-rop0.1% Pf200mlns Cadd-yfsff | Fent2mcg/ml-rop0.1% Pf200mlns Cadd-yfsff | 200 mL in 1 CARTRIDGE | Injection | Epidural | Quva Pharma, Inc. |
70092-441-76 | Fent2mcg/ml-rop0.1% Pf200mlns Cadd-yfsff | Fent2mcg/ml-rop0.1% Pf200mlns Cadd-yfsff | 200 mL in 1 CARTRIDGE | Injection | Epidural | Quva Pharma, Inc. |
70092-441-76 | Fent2mcg/ml-rop0.1% Pf200mlns Cadd-yfsff | Fent2mcg/ml-rop0.1% Pf200mlns Cadd-yfsff | 200 mL in 1 CARTRIDGE | Injection | Epidural | Quva Pharma, Inc. |
70092-504-36 | Fent 2 Mcg/ml-ropiv 0.2% Pf 100ml Ns Ivb | Fent 2 Mcg/ml-ropiv 0.2% Pf 100ml Ns Ivb | 100 mL in 1 BAG | Injection | Epidural | Quva Pharma, Inc. |
70092-504-36 | Fent 2 Mcg/ml-ropiv 0.2% Pf 100ml Ns Ivb | Fent 2 Mcg/ml-ropiv 0.2% Pf 100ml Ns Ivb | 100 mL in 1 BAG | Injection | Epidural | Quva Pharma, Inc. |
70092-504-36 | Fent 2 Mcg/ml-ropiv 0.2% Pf 100ml Ns Ivb | Fent 2 Mcg/ml-ropiv 0.2% Pf 100ml Ns Ivb | 100 mL in 1 BAG | Injection | Epidural | Quva Pharma, Inc. |
Frequently Asked Questions
What is the NDC number assigned to Fent 2 Mcg/ml-ropiv 0.2% Pf 100ml Ns Ivb?
Fent 2 Mcg/ml-ropiv 0.2% Pf 100ml Ns Ivb was assigned by its manufacturer with NDC product code 60652-4272. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.
Which are the NDC package codes for Fent 2 Mcg/ml-ropiv 0.2% Pf 100ml Ns Ivb?
The NDC package code 60652-4272-1 was assigned to a 150 mL in 1 BAG of fentanyl citrate; ropivacaine hydrochloride administered epidural via injection.
Who manufactures this product?
Fent 2 Mcg/ml-ropiv 0.2% Pf 100ml Ns Ivb is manufactured by an outsourced facility and labeled by Ssm Hlth St Clare Hosp-fnton. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.
Which are the NDC crossover matchings for this product?
We found 16 matching products that have the same substance, dosage form and administration route. The matching products are manufactured by QuVa Pharma, Inc. with NDC product codes 70092-108-36, 70092-108-36, 70092-108-36, 70092-108-36, 70092-207-37, 70092-225-37, 70092-225-37, 70092-399-75, 70092-399-75, 70092-441-76, 70092-441-76, 70092-441-76, 70092-441-76, 70092-504-36, 70092-504-36 and 70092-504-36.